Effect of Gadolinium on the Estimation of Myelin and Brain Tissue Volumes Based on Quantitative Synthetic MRI

References

1. 1.↵
   2. Warntjes JB,
   3. Leinhard OD,
   4. West J, et al

   . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127

   CrossRefPubMed
2. 2.↵
   2. Blystad I,
   3. Warntjes JB,
   4. Smedby O, et al

   . Synthetic MRI of the brain in a clinical setting. Acta Radiol 2012;53:1158–63 doi:10.1258/ar.2012.120195 pmid:23024181

   CrossRefPubMed
3. 3.↵
   2. Hagiwara A,
   3. Warntjes M,
   4. Hori M, et al

   . SyMRI of the brain: rapid quantification of relaxation rates and proton density, with Synthetic MRI, automatic brain segmentation, and myelin measurement. Invest Radiol 2017;52:647–57 doi:10.1097/RLI.0000000000000365 pmid:28257339

   CrossRefPubMed
4. 4.↵
   2. Wallaert L,
   3. Hagiwara A,
   4. Andica C, et al

   . The advantage of synthetic MRI for the visualization of anterior temporal pole lesions on double inversion recovery (DIR), phase-sensitive inversion recovery (PSIR), and myelin images in a patient with CADASIL. Magn Reson Med Sci 2018;17:275–76 doi:10.2463/mrms.ci.2017-0110 pmid:29238005

   CrossRefPubMed
5. 5.↵
   2. Krauss W,
   3. Gunnarsson M,
   4. Andersson T, et al

   . Accuracy and reproducibility of a quantitative magnetic resonance imaging method for concurrent measurements of tissue relaxation times and proton density. Magn Reson Imaging 2015;33:584–91 doi:10.1016/j.mri.2015.02.013 pmid:25708264

   CrossRefPubMed
6. 6.↵
   2. Hagiwara A,
   3. Hori M,
   4. Cohen-Adad J, et al

   . Linearity, bias, intra-scanner repeatability, and inter-scanner reproducibility of quantitative multi-dynamic multi-echo sequence for rapid simultaneous relaxometry at 3T: a validation study with a standardized phantom and healthy controls. Invest Radiol 2018 Sep 5. [Epub ahead of print] doi:10.1097/RLI.0000000000000510 pmid:30300164

   CrossRefPubMed
7. 7.↵
   2. West J,
   3. Warntjes JB,
   4. Lundberg P

   . Novel whole brain segmentation and volume estimation using quantitative MRI. Eur Radiol 2012;22:998–1007 doi:10.1007/s00330-011-2336-7 pmid:22113264

   CrossRefPubMed
8. 8.↵
   2. Andica C,
   3. Hagiwara A,
   4. Hori M, et al

   . Automated brain tissue and myelin volumetry based on quantitative MR imaging with various in-plane resolutions. J Neuroradiol 2018;45:164–68 doi:10.1016/j.neurad.2017.10.002 pmid:29132939

   CrossRefPubMed
9. 9.↵
   2. Granberg T,
   3. Uppman M,
   4. Hashim F, et al

   . Clinical feasibility of synthetic MRI in multiple sclerosis: a diagnostic and volumetric validation study. AJNR Am J Neuroradiol 2016;37:1023–29 doi:10.3174/ajnr.A4665 pmid:26797137

   Abstract/FREE Full Text
10. 10.↵
    2. Warntjes M,
    3. Engström M,
    4. Tisell A, et al

    . Modeling the presence of myelin and edema in the brain based on multi-parametric quantitative MRI. Front Neurol 2016;7:16 doi:10.3389/fneur.2016.00016 pmid:26925030

    CrossRefPubMed
11. 11.↵
    2. Hagiwara A,
    3. Hori M,
    4. Yokoyama K, et al

    . Utility of a multiparametric quantitative MRI model that assesses myelin and edema for evaluating plaques, periplaque white matter, and normal-appearing white matter in patients with multiple sclerosis: a feasibility study. AJNR Am J Neuroradiol 2017;38:237–42 doi:10.3174/ajnr.A4977 pmid:27789453

    Abstract/FREE Full Text
12. 12.↵
    2. Warntjes JBM,
    3. Persson A,
    4. Berge J, et al

    . Myelin detection using rapid quantitative MR imaging correlated to macroscopically registered Luxol fast blue-stained brain specimens. AJNR Am J Neuroradiol 2017;38:1096–102 doi:10.3174/ajnr.A5168 pmid:28428209

    Abstract/FREE Full Text
13. 13.↵
    2. Hagiwara A,
    3. Hori M,
    4. Kamagata K, et al

    . Myelin measurement: comparison between simultaneous tissue relaxometry, magnetization transfer saturation index, and T1w/T2w ratio methods. Sci Rep 2018;8:10554 doi:10.1038/s41598-018-28852-6 pmid:30002497

    CrossRefPubMed
14. 14.↵
    2. Warntjes JB,
    3. Tisell A,
    4. Landtblom AM, et al

    . Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis. AJNR Am J Neuroradiol 2014;35:1330–36 doi:10.3174/ajnr.A3890 pmid:24699093

    Abstract/FREE Full Text
15. 15.↵
    2. Hagiwara A,
    3. Hori M,
    4. Suzuki M, et al

    . Contrast-enhanced synthetic MRI for the detection of brain metastases. Acta Radiol Open 2016;5:2058460115626757 doi:10.1177/2058460115626757 pmid:26962461

    CrossRefPubMed
16. 16.↵
    2. Zhang Y,
    3. Brady M,
    4. Smith S

    . Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57 doi:10.1109/42.906424 pmid:11293691

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Naganawa S,
    3. Nakane T,
    4. Kawai H, et al

    . Gd-based contrast enhancement of the perivascular spaces in the basal ganglia. Magn Reson Med Sci 2017;16:61–65 doi:10.2463/mrms.mp.2016-0039 pmid:27430361

    CrossRefPubMed
18. 18.↵
    2. Ambarki K,
    3. Lindqvist T,
    4. Wåhlin A, et al

    . Evaluation of automatic measurement of the intracranial volume based on quantitative MR imaging. AJNR Am J Neuroradiol 2012;33:1951–56 doi:10.3174/ajnr.A3067 pmid:22555574

    Abstract/FREE Full Text
19. 19.↵
    2. Duval T,
    3. Stikov N,
    4. Cohen-Adad J

    . Modeling white matter microstructure. Funct Neurol 2016;31:217–28 pmid:28072382

    PubMed
20. 20.↵
    2. Alonso-Ortiz E,
    3. Levesque IR,
    4. Pike GB

    . MRI-based myelin water imaging: a technical review. Magn Reson Med 2015;73:70–81 doi:10.1002/mrm.25198 pmid:24604728

    CrossRefPubMed
21. 21.↵
    2. Mezer A,
    3. Yeatman JD,
    4. Stikov N, et al

    . Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging. Nat Med 2013;19:1667–72 doi:10.1038/nm.3390 pmid:24185694

    CrossRefPubMed
22. 22.↵
    2. Glasser MF,
    3. Van Essen DC

    . Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci 2011;31:11597–616 doi:10.1523/JNEUROSCI.2180-11.2011 pmid:21832190

    Abstract/FREE Full Text
23. 23.↵
    2. Hagiwara A,
    3. Hori M,
    4. Yokoyama K, et al

    . Analysis of white matter damage in patients with multiple sclerosis via a novel in vivo MR method for measuring myelin, axons, and g-ratio. AJNR Am J Neuroradiol 2017;38:1934–40 doi:10.3174/ajnr.A5312 pmid:28775058

    Abstract/FREE Full Text
24. 24.↵
    2. Jeon JY,
    3. Choi JW,
    4. Roh HG, et al

    . Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrol. Korean J Radiol 2014;15:145–50 doi:10.3348/kjr.2014.15.1.145 pmid:24497805

    CrossRefPubMed
25. 25.↵
    2. Warntjes JB,
    3. Tisell A,
    4. Håkansson I, et al

    . Improved precision of automatic brain volume measurements in patients with clinically isolated syndrome and multiple sclerosis using edema correction. AJNR Am J Neuroradiol 2018;39:296–302 doi:10.3174/ajnr.A5476 pmid:29242365

    Abstract/FREE Full Text
26. 26.↵
    2. Kanda T,
    3. Ishii K,
    4. Kawaguchi H, et al

    . High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270:834–41 doi:10.1148/radiol.13131669 pmid:24475844

    CrossRefPubMed
27. 27.↵
    2. Errante Y,
    3. Cirimele V,
    4. Mallio CA, et al

    . Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014;49:685–90 doi:10.1097/RLI.0000000000000072 pmid:24872007

    CrossRefPubMed
28. 28.↵
    2. Adin ME,
    3. Kleinberg L,
    4. Vaidya D, et al

    . Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration. AJNR Am J Neuroradiol 2015;36:1859–65 doi:10.3174/ajnr.A4378 pmid:26294649

    Abstract/FREE Full Text
29. 29.↵
    2. McDonald RJ,
    3. McDonald JS,
    4. Kallmes DF, et al

    . Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015;275:772–82 doi:10.1148/radiol.15150025 pmid:25742194

    CrossRefPubMed
30. 30.↵
    2. Kanda T,
    3. Fukusato T,
    4. Matsuda M, et al

    . Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015;276:228–32 doi:10.1148/radiol.2015142690 pmid:25942417

    CrossRefPubMed
31. 31.↵
    2. Murata N,
    3. Gonzalez-Cuyar LF,
    4. Murata K, et al

    . Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Invest Radiol 2016;51:447–53 doi:10.1097/RLI.0000000000000252 pmid:26863577

    CrossRefPubMed